ALXN

Q: What is the price of Alexion Pharmaceuticals (ALXN) today?

The price of Alexion Pharmaceuticals (ALXN) today is $ 0.00, with return of 0% compared to the last year. The price of Alexion Pharmaceuticals (ALXN) started the year trading around $ 0.00 and today it is at $ 0.00. Follow the real-time price chart, the historical price of Alexion Pharmaceuticals (ALXN) and international markets.

Q: When does Alexion Pharmaceuticals (ALXN) pay dividends?

Alexion Pharmaceuticals (ALXN) did not distribute dividends in the last year.

Q: Is Alexion Pharmaceuticals (ALXN) worth it?

Currently, Alexion Pharmaceuticals (ALXN) is priced at $ 0.00, with a P/E of 58.89%, representing a deviation of 0% from its historical average P/E. In the last year, the stock showed a variation of 0 in its price and distributed $ 0.00 in dividends, resulting in a Dividend Yield of 0.00%. The total shareholder return was 0.00%.It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Q: How can I buy Alexion Pharmaceuticals (ALXN) stock?

Investing in stocks of Alexion Pharmaceuticals (ALXN) can be done in two ways: by buying the stock abroad. The stock is the original stock, traded on international exchanges. By buying it, you invest with money outside Brazil, which brings greater geographical and currency diversification.BDR is a receipt for that stock, traded on the B3 with reais, through a brazilian brokerage. Although the money remains in Brazil, the BDR still offers diversification, as it represents a foreign company and is linked to the dollar.

Q: How much would 100 shares of Alexion Pharmaceuticals (ALXN) yield today?

The yield of Alexion Pharmaceuticals (ALXN) was 0.00% in the last month, 0.00% in the last year and 0.00% in the last 5 years (already considering appreciation and dividends).In the last 12 months, the company paid a total of $ 0.00 in dividends, with a Dividend Yield of 0.00%.If you wanted to buy 100 stocks of Alexion Pharmaceuticals (ALXN) today, the total investment would be $ 0.00, based on the current price of $ 0.00.If past performance were to repeat, the return on your investment would be:In 1 year: $ 0.00In 5 years: $ 0.00In 10 years: $ 0.00It is important to remember that past performance does not guarantee future results. This should not be seen as an investment recommendation.

Alexion Pharmaceuticals Inc.

This asset is no longer available for investment.

View all assets

Price

$ -

return (12m)

0.00%

p/e

58.89

p/bv

3.23

DIVIDEND YIELD

0.00%

ALXN price

ALXN

If you had invested

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

ago, you would now have *

ago, you would now have:

*The figure considers the reinvestment of dividends.

Return on Investment ALXN

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

0.00%

3 months

0.00%

1 year

0.00%

2 years

0.00%

5 years

0.00%

10 years

0.00%

Fundamentals ALXN

review the fundamentals of Alexion Pharmaceuticals shares

P/E

58.89

Sector: -4.36 Industry: -13.38

P/S (PSR)

6.41

Sector: 1.79 Industry: 2.90

P/BV

3.23

Sector: 2.09 Industry: 1.79

DIVIDEND YIELD (DY)

0.00%

Sector: - Industry: -

ROA

3.66%

Sector: -30.33% Industry: -67.81%

ROE

5.48%

Sector: -39.83% Industry: -59.34%

ROIC

19.10%

Sector: -418.66% Industry: -484.72%

NET MARGIN

10.89%

Sector: -32.52% Industry: -43.03%

GROSS MARGIN

90.94%

Sector: 42.44% Industry: 41.46%

OPERATING MARGIN

47.07%

Sector: -27.49% Industry: -38.68%

EV/EBITDA

43.19

Sector: -2.68 Industry: -9.74

EV/EBIT

65.39

Sector: -3.96 Industry: -11.20

PRICE-TO-ASSETS

2.15

Sector: 1.06 Industry: 1.14

BVPS

56.50

Sector: 3.44 Industry: 1.62

EPS

3.10

Sector: -1.07 Industry: -1.89

EQUITY-TO-ASSETS RATIO

0.67

Sector: 0.39 Industry: 0.32

LIABILITIES / ASSETS

0.33

Sector: 0.45 Industry: 0.36

CAGR REVENUE 5 YEARS

30.78%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

1.40%

Sector: - Industry: -

FAIR VALUE OF Alexion Pharmaceuticals ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$ 0.00

Fair Value

$ 0.00

Upside/Downside Return potential.

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals ALXN

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	40.57	35.11	86.53%	0.67%	$ 837.34 B	31.66%
ISRG	56.19	8.94	15.92%	0.00%	$ 160.48 B	28.38%
TMO	27.56	3.45	12.52%	0.35%	$ 184.79 B	15.05%
SNY	12.82	1.39	10.86%	4.62%	$ 116.90 B	18.68%
NVS	21.09	6.34	30.04%	4.53%	$ 294.97 B	24.67%
ABT	27.37	3.48	12.73%	2.34%	$ 178.54 B	14.72%
MDT	24.09	2.26	9.38%	3.27%	$ 111.15 B	13.00%
CVS	52.79	1.24	2.35%	3.62%	$ 93.33 B	0.44%
GSK	14.82	5.29	35.71%	2.96%	$ 113.04 B	17.48%
BSX	32.15	0.00	0.00%	0.00%	$ 93.16 B	14.44%
TMDX	17.99	7.24	40.22%	0.00%	$ 3.42 B	31.43%
HCA	15.86	-38.82	-244.82%	0.62%	$ 107.58 B	8.97%
IDXX	43.01	28.38	65.99%	0.00%	$ 45.56 B	24.62%
RMD	22.02	5.18	23.51%	1.04%	$ 32.72 B	27.53%
DHR	37.39	2.57	6.88%	0.67%	$ 135.12 B	14.71%
INMD	9.26	1.27	13.73%	0.00%	$ 868.77 M	25.32%
PHG	24.85	2.00	8.06%	3.27%	$ 25.78 B	5.07%
FMS	11.36	0.77	6.75%	3.51%	$ 12.82 B	5.02%
SYK	39.12	5.66	14.48%	1.03%	$ 126.98 B	12.92%

Stock vs Indice Comparison Tool

If you had invested (change) 2 years years ago, ago, you would now have

R$ 1.000,00 in PETR4 You would now have R$ 2.294,60

R$ 1.000,00 in LEVE3 You would now have R$ 5.240,60

*The value considers the reinvestment of dividends.

ALXN Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Alexion Pharmaceuticals

Alexion Pharmaceuticals Inc.

Average Investor10 user rating

4.0 (1 people)

United States

34 years

Founded: 1992

1996

Time since IPO - 30 years

3.837

Employees

The Company Alexion Pharmaceuticals Inc. (United States), is listed on Nasdaq with a market value of $ 40.15 Billions, having an equity of $ 12.43 Billions.

With a total of 3.837 employees, the company is listed in the sector of Health and categorized in industry of Main Medications.

In the last 12 months the Company had a revenue of $ 6.26 Billions, which generated a profit in the amount of $ 681.80 Millions.

As for its main indicators, the Company has a P/E ratio of 58.89, a P/BV ratio of 3.23 and in the last 12 months the Company did not pay dividends.

The Company is traded internationally through the ticker ALXN.

Market cap

$ 40.15 Billions

Net worth

$ 12.43 Billions

US$ 12,431,000,000.00

Assets

$ 18.65 Billions

US$ 18,650,200,000.00

Total Shares Outstanding

220.00 Millions

220,000,000

Average Daily Trading Volume

$ 5.81 Millions

US$ 5,809,888.66

Sector

Health

Industry

Main Medications

ALXN

ALXN revenue and profits

Financial Results ALXN

DRAG THE FRAME TO SEE MORE DATA

ALXN cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

LBPSW - 4D pharma

$ - -0,00% (12M)

P/E

0.00

0.00%

ROE

-300.00%

P/BV

0.00

CVS - CVS Health

$ 73.49 20,94% (12M)

P/E

52.79

3.62%

ROE

2.35%

P/BV

1.24

CI - Cigna

$ 270.02 --14,47% (12M)

P/E

10.45

2.26%

ROE

0.00%

P/BV

0.00

CNC - Centene

$ 35.11 --43,31% (12M)

P/E

-2.59

0.00%

ROE

-33.28%

P/BV

0.86

HUM - Humana

$ 177.83 --28,58% (12M)

P/E

17.96

1.99%

ROE

6.70%

P/BV

1.20

HCA - HCA Healthcare

$ 471.84 43,24% (12M)

P/E

15.86

0.62%

ROE

-244.82%

P/BV

-38.82

LLY - Eli Lilly

$ 935.58 30,21% (12M)

P/E

40.57

0.67%

ROE

86.53%

P/BV

35.11

NVS - Novartis

$ 154.03 53,71% (12M)

P/E

21.09

4.53%

ROE

30.04%

P/BV

6.34